Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Meda
Meda
Activities:
Manufacturing
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Finance
Mylan to acquire Meda in US$9.9bn cash and stock deal
Will create a leading pharma firm with a portfolio of branded and generic medicines and a strong portfolio of over-the-counter products
Manufacturing
DPT Laboratories acquires Meda Pharmaceuticals New Jersey facility
Will meet the current need for additional cold storage and a larger analytical laboratory
Finance
Meda to acquire Rottapharm for around €3bn in cash and shares
Expanding its business in consumer healthcare products and in emerging markets
Finance
Meda to acquire Acton Pharmaceuticals for US$135m
Transaction includes the Aerospan inhaler for the treatment of asthma
Research & Development
Meda expands collaboration with Cipla
Expands its exclusive rights to allergic rhinitis treatment Dymista
Subscribe now